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Background
World Health Organization position paper on immu-
notherapy recommends using mite allergen vaccines for
rhinitis and mild to moderate asthma. Allergic sensitiza-
tion to domestic mites and particularly to Dermatopha-
goides pteronyssinus, Dermatophagoides siboney and
Blomia tropicalis has been described before in Cuba, as
strongly linked to respiratory allergy symptoms. The aim
of this work was to study the therapeutic effect and safety
of allergen vaccines of these 3 mite species (VALERGEN,
BIOCEN, Cuba) by subcutaneous route, in asthmatic
patients.
Methods
Three Double-Blind Placebo-Controlled clinical trials
were performed in 40 patients each, showing asthmatic
symptoms and positive predominant Skin Prick Test
(SPT) to each mite, respectively. Half of patients received
the active treatment consisting of subcutaneous injec-
tions with increasing doses, up to 6000 BU. Therapeutic
effect was assessed after 6 and 12 months using symp-
toms/medication diary cards, peak expiratory flow (PEF)
measures and skin sensitivity to investigated mites.
Adverse reactions were classified using the World Allergy
Organization scale.
Results
The total 1 year cumulative dose was 63035 BU, in an
average of 20.5 injections. The treatment was effective
in the reduction of clinical symptoms (up to 32%, 95%
CI:28-36%; p=0.0006) and medication intake (23%, 95%
CI:18-28%), as compared to control treatment. The skin
sensitivity to the allergens decreased significantly
(p=0.0001), with regard to the beginning of the treat-
ment. The allergen amount needed to induce a positive
SPT increased 297-fold. Improvement of the lung func-
tion was observed, expressed in a modest Peak-Expira-
tory-Flow increase (p<0.05) and reduction of PEF daily
variability. SIT was considered effective in 71% of
patients. The frequency of local adverse reactions was
2.4 % of injections.
Conclusions
Summing up subcutaneous immunotherapy, using
VALERGEN vaccines, is effective and safe for the con-
trol and amelioration of the asthma.
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